Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ICCC
#3451
Immucell Corp
6.4
0
+0.79%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+0.79%
Monatliche Änderung
+0.63%
6 month change
+4.40%
Jahresänderung
+21.67%
Vorheriger Schlusskurs
6.3
5
Open
6.4
0
Bid
Ask
Low
6.4
0
High
6.4
0
Volumen
3
Märkte
Aktien
Gesundheitswesen
ICCC
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
8.91 M
8.98 M
9.04 M
9.05 M
9.05 M
—
Valuation ratios
Enterprise value
32.1 M
46.01 M
43.04 M
62.71 M
52.65 M
204.41 M
Price to earnings ratio
-7.26
-19.81
-119.75
31.64
21.55
-86.37
Price to sales ratio
1.2
1.59
1.46
2.11
1.97
7.13
Price to cash flow ratio
-84.13
117.52
28
25.41
28.22
199.16
Price to book ratio
0.29
1.53
0.37
0.53
0.47
2.9
Enterprise value to EBITDA ratio
18.44
42.22
17.01
13.98
10.32
83.53
Profitability ratios
Return on assets %
-0.02
0.01
0.03
0.01
-0
0.05
Return on equity %
-0.03
0.02
0.05
0.02
-0
0.08
Return on invested capital %
-5.78
5.85
10.41
5.2
0.2
21.66
Gross margin %
26.34
36.53
41.58
43.72
42.92
164.75
Operating margin %
-9.56
8.02
13.85
8.84
0.36
31.07
EBITDA margin %
1.85
17.03
22.37
19.37
13.24
72.01
Net margin %
-11.67
6.64
17.94
7.79
-2.54
29.82
Liquidity ratios
Quick ratio
1.44
1.8
2.21
1.99
1.76
7.76
Current ratio
3.11
3.41
4.12
3.85
4.21
15.59
Inventory turnover
0.6
0.68
0.65
0.46
—
—
Asset turnover
0.14
0.17
0.18
0.14
0.12
0.61
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.24
0.23
0.22
0.18
0.17
0.81
Long term debt to total equity ratio
0.41
0.38
0.35
0.28
0.27
1.28
Per share metrics
Operating cash flow per share
-0.08
-0
0.18
0.18
-0.13
0.22
EBIT per share
-0.07
0.08
0.12
0.06
0
0.27
EBITDA per share
0.01
0.16
0.2
0.14
0.08
0.58
Total debt per share
—
—
—
—
—
—
Cash per share
0.03
0.03
0.03
0.03
0.43
0.52
Net current asset value per share
1.7
1.84
1.77
1.9
1.86
7.37
Tangible book value per share
3.22
3.36
3.22
3.3
3.28
13.15
Working capital per share
1.15
1.3
1.34
1.41
1.42
5.47
Book value per share
3.23
3.37
3.23
3.31
3.29
13.2
Nachrichten
ImmuCell: Zwei Verwaltungsratsmitglieder treten 2026 nicht zur Wiederwahl an
ImmuCell directors to step down at 2026 annual meeting, board changes expected
ImmuCell: Neue Arbeitsverträge und Aktienoptionen für Führungskräfte
ImmuCell announces new executive employment agreements and option grants
Niche Focus & Regulation Shape the Future of Healthcare Firms
ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript
Earnings Call Transkript: ImmuCell-Aktie legt nach gemischten Q4-Zahlen 2025 zu
Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement
ImmuCell meldet Q4-Umsatz von 7,6 Mio. US-Dollar und richtet Fokus neu auf First Defense
ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense
ImmuCell Puts Re-Tain On Pause After FDA Letter - ImmuCell (NASDAQ:ICCC)
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio